Genmab A/S (GMAB) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-02-17 16:14:57 ET
Genmab A/S (GMAB) Q4 2025 Earnings Call February 17, 2026 12:00 PM EST
Company Participants
Jan van de Winkel - Co-Founder, President & CEO
Brad Bailey
Anthony Pagano - Executive VP & CFO
Tahamtan Ahmadi - Executive VP, Chief Medical Officer & Head of Experimental Medicines
Judith Klimovsky - Executive VP & Chief Development Officer
...
Read the full article on Seeking Alpha
For further details see:
Genmab A/S (GMAB) Q4 2025 Earnings Call Transcript
Genmab A/S
NASDAQ: GMAB
GMAB Trading
-2.86% G/L:
$28.32 Last:
273,824 Volume:
$28.98 Open:
GMAB Latest News
GMAB Stock Data
$20,372,415,851
653,797,023
N/A
122
N/A
Biotechnology & Life Sciences
Healthcare
DK
Valby
